Novel Foods, Food Additives, and Product Classification

Why the classification decision is the most consequential regulatory question a new food product faces.

Before a food company can answer any compliance question, labelling, claims, manufacturing, inspection, it must first answer a prior question: what is this product? The regulatory classification determines which regime applies. A product classified as a food faces one set of requirements. The same product classified as a novel food, a food additive, a processing aid, a natural health product, a supplemented food, or a drug faces a different regime with different obligations, different regulators, and different timelines. Getting the classification wrong means building on the wrong regulatory foundation.

The Novelty Determination

For products or ingredients without a history of safe use in Canada, the first question is whether the product is "novel." Health Canada defines a novel food as a product that does not have a history of safe use as a food in Canada, has been manufactured or processed in a way that has not previously been applied to that food and that causes a major change in the product, or is derived from a genetically modified organism. A product that meets any of these criteria requires a pre-market notification to Health Canada and cannot be sold until Health Canada completes its safety assessment.

The novelty determination is not always straightforward. A product sold safely in the United States or Europe for decades may still be novel in Canada if it lacks a history of Canadian consumption. An ingredient processed using a new technology (novel extraction methods, fermentation-derived ingredients with no history of safe use, cell-based production processes) may trigger novelty even if the starting material is conventional.

In practice, the classification traps are predictable. An imported functional beverage with a botanical ingredient that has no Canadian consumption history. A high-caffeine product that could be classified as food, supplemented food, or NHP depending on the formulation and the claims. A product positioned and consumed as "wellness" food but formulated in a way that crosses the NHP or drug boundary. These are the cases where the classification analysis prevents a costly wrong turn.

One additional complication in edge cases: ECCC administers the New Substances Notification Regulations under CEPA. Substances not on the Domestic Substances List require notification and assessment before manufacture or import. For biotech-derived ingredients or novel chemical substances, this can create a dual-track obligation alongside Health Canada's novel food process.

The Classification Spectrum

Beyond novelty, the classification question maps onto a spectrum of regulatory categories, each governed by different statutes and regulators.

Food (conventional): subject to the FDA, FDR, SFCA, and SFCR. No pre-market approval required (unless novel).

Food additive: a substance that becomes part of or affects the characteristics of a food through its use. Food additives must appear on Health Canada's Lists of Permitted Food Additives, which are the operative framework (the older Division 16 tables in the FDR temporarily coexist but are being replaced). A substance not on a permitted list cannot be used. The distinction between an additive and an ingredient turns on function.

Supplemented food: a prepackaged product in a permitted food category with one or more supplemental ingredients added under conditions in the List of Permitted Supplemental Ingredients. The regime is FDR Division 29, operative since January 1, 2026. Classification triggers the Supplemented Food Facts table, cautionary statements, and the caution identifier, and it pulls the product out of the conventional labelling regime. See Supplemented Foods.

Natural health product: a product making a health claim within the NHP framework. The NHP/food boundary is particularly contested for functional foods, fortified beverages, and wellness-positioned products. Classification requires a product licence from Health Canada.

Drug: a product that claims to treat, prevent, or mitigate a disease. The drug/food boundary is the most consequential classification line. For animal products, the veterinary health product and veterinary drug classifications raise parallel issues. See Pet Food Regulation.

Where Counsel Fits

The classification analysis is the highest-value pre-market engagement because it prevents the company from investing in a product pathway that turns out to be wrong. Reformulating, relabelling, or repositioning after the wrong classification has been assumed is significantly more expensive than getting the classification right at the outset.

Counsel's work here is typically: conducting the novelty assessment; mapping the product against the classification categories; developing a regulatory pathway that accounts for the applicable requirements; and, where the classification is genuinely uncertain, advising on a pre-market consultation strategy with Health Canada. Companies entering Canada from other markets are the most common engagement. The assumption that an existing classification transfers is frequently wrong.

GSJ&Co. advises on novelty determinations, product classification, and regulatory pathway analysis. Contact info@gsjameson.com or +1 (647) 638-3994.

Primary Authorities

Last updated: March 2026. This page is maintained by GSJ&Co. and updated when there are material changes to the novel food or product classification framework.